Back to results
US 12,668,785 B2Granted
Combination treatment by administering a recombinant apyrase protein in conjunction with a P2Y12 inhibitor
AssigneeAstraZeneca AB
InventorsLeif Carlsson, Sven Nylander, Ola Fjellstrom, Lina Badimon Maestro
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating ischemic events in a patient, especially ST-segment elevation myocardial infarction and acute ischemic stroke, by administrating a recombinant apyrase protein in conjunction with a P2Y12 inhibitor.
Claims10
A method of treating an ischemic event in a patient, the method comprising sequentially or simultaneously administering to the patient a recombinant apyrase protein comprising the amino acid sequence of SEQ ID NO:
- 2 and ticagrelor, wherein the ischemic event is ST-segment elevation myocardial infarction (STEMI).
Dependencies are inferred from the claim text.